-
-
-
-
-
-
-
Stifel Starts BridgeBio Oncology Therapeutics, In (BBOT) at Buy
-
-
-
-
-
-
-
Morgan Stanley Starts BridgeBio Oncology Therapeutics, In (BBOT) at Overweight
-
-
-
-
-
-
-
BBOT begins trading on Nasdaq after $382M SPAC merger completion
428,374 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

